GlassScriptPhysician profile
Madison Luce Huser
NPI 1255684775
$1,671.46
in general payments reported to CMS, 2019-2025
20 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.77 · 2020: $89.14 · 2021: $264 · 2022: $405 · 2023: $240 · 2024: $414 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Entertainment: $40.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.64 |
| Entertainment | $40.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $264.11 | 2022-2025 | Infuse, Miebo, Xiidra |
| Biotissue Holdings INC. | $242.86 | 2022-2024 | |
| Alcon Vision LLC | $215.51 | 2019-2024 | Total30, Dailies Total1 |
| Optos, INC. | $161.58 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $139.95 | 2021 | |
| Oyster Point Pharma, INC. | $105.31 | 2022-2025 | Tyrvaya, Ryzumvi |
| Coopervision INC. | $103.82 | 2024 | Synergeyes Contact Lens, Onefit Contact Lens |
| Abbvie INC. | $93.61 | 2022-2024 | |
| Allergan, INC. | $77.23 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $53.85 | 2020-2021 | |
| Eyevance Pharmaceuticals LLC | $32.23 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $31.73 | 2023-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $29.04 | 2025 | Xdemvy |
| Harrow Eye, LLC | $24.18 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $20.45 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $18.34 | 2019 | |
| Rxsight INC | $17.81 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $15.52 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.20 | 2019 | |
| Visioneering Technologies, INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Huser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.